Quest Diagnostics Ranks No. 1 in Industry Category on FORTUNE's World's Most Admired Companies List
MADISON, N.J., March 4, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that that it has been recognized in FORTUNE magazine's "World's Most Admired Companies" list as the No. 1 company in the Health Care industry category of "Pharmacy and Other Services."
"We are proud that Quest Diagnostics has rejoined FORTUNE's World's Most Admired Companies as the leader in our category," said Steve Rusckowski , President and CEO. "This accomplishment reflects the passion of our employees, who every day empower better health with diagnostic insights for people throughout the communities we serve."
FORTUNE's list of Most Admired Companies is based on surveys of thousands of executives, directors and securities analysts based on nine criteria: innovation, people management, use of corporate assets, quality of management; social responsibility; financial soundness, long-term investment, quality of products and services, and global competitiveness.
The ranking for Quest Diagnostics may be found online at http://money.cnn.com/magazines/fortune/most-admired/2013/snapshots/10577.html
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.
Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.
Quest Diagnostics Contacts:
Dan Haemmerle (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800
SOURCE Quest Diagnostics
RELATED LINKS
http://www.questdiagnostics.com
More by this Source
Quest Diagnostics Declares Quarterly Cash Dividend
May 21, 2013, 14:16 ET
Decades of Improving Cholesterol Levels Abruptly Ended in 2008, PLOS ONE Study Finds
May 13, 2013, 14:58 ET
Quest Diagnostics to Acquire Lab-Related Clinical Outreach Operations of Dignity Health in California and Nevada
Apr 17, 2013, 06:23 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.